ES549313A0 - Procedimiento para aumentar la adherencia de las bacterias en el estomago e intestinos de seres humanos y animales - Google Patents

Procedimiento para aumentar la adherencia de las bacterias en el estomago e intestinos de seres humanos y animales

Info

Publication number
ES549313A0
ES549313A0 ES549313A ES549313A ES549313A0 ES 549313 A0 ES549313 A0 ES 549313A0 ES 549313 A ES549313 A ES 549313A ES 549313 A ES549313 A ES 549313A ES 549313 A0 ES549313 A0 ES 549313A0
Authority
ES
Spain
Prior art keywords
bacteria
pct
intestines
stomach
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549313A
Other languages
English (en)
Other versions
ES8700938A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemical Dynamics Sweden AB
Original Assignee
Chemical Dynamics Sweden AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical Dynamics Sweden AB filed Critical Chemical Dynamics Sweden AB
Publication of ES8700938A1 publication Critical patent/ES8700938A1/es
Publication of ES549313A0 publication Critical patent/ES549313A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Feed For Specific Animals (AREA)
ES549313A 1984-11-08 1985-11-08 Procedimiento para aumentar la adherencia de las bacterias en el estomago e intestinos de seres humanos y animales Expired ES8700938A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8405587A SE463598B (sv) 1984-11-08 1984-11-08 Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta

Publications (2)

Publication Number Publication Date
ES8700938A1 ES8700938A1 (es) 1986-11-16
ES549313A0 true ES549313A0 (es) 1986-11-16

Family

ID=20357659

Family Applications (2)

Application Number Title Priority Date Filing Date
ES549313A Expired ES8700938A1 (es) 1984-11-08 1985-11-08 Procedimiento para aumentar la adherencia de las bacterias en el estomago e intestinos de seres humanos y animales
ES557029A Expired ES8705229A1 (es) 1984-11-08 1986-07-16 Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557029A Expired ES8705229A1 (es) 1984-11-08 1986-07-16 Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales

Country Status (11)

Country Link
US (1) US4767623A (es)
EP (1) EP0201579B1 (es)
JP (1) JPH0720876B2 (es)
AT (1) ATE81290T1 (es)
CA (1) CA1266234A (es)
DE (1) DE3586744T2 (es)
DK (1) DK172252B1 (es)
ES (2) ES8700938A1 (es)
FI (1) FI85810C (es)
SE (1) SE463598B (es)
WO (1) WO1986002837A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
SE8900546D0 (sv) * 1989-02-17 1989-02-17 Bioinvent Int Ab Medel foer inhibering av patogeners adhesion tillvaext och /eller oeverlevnad
IL101410A0 (en) * 1992-03-29 1992-11-15 Era Masis Ltd Formulation for the treatment of cancer
AUPM823094A0 (en) * 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
EP0955058B1 (en) * 1997-01-09 2004-05-26 Morinaga Milk Industry Co., Ltd. Lactoferrin tablets
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
CN1304313A (zh) * 1998-06-05 2001-07-18 若素制药株式会社 含乳酸菌的组合物、药物和食物
US6645515B1 (en) * 1998-11-26 2003-11-11 Meito Sangyo Kabushiki Kaisha Bacteriostatic composition for salmonellae
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AU2006236629B2 (en) * 2005-04-15 2012-04-19 North Carolina State University Methods and compositions to modulate adhesion and stress tolerance in bacteria
BRPI0611492B1 (pt) * 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
WO2006130187A1 (en) * 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634858A (es) * 1962-07-19 1900-01-01
SE371209B (es) * 1969-10-13 1974-11-11 Cernelle Ab
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
DE2738652C3 (de) * 1977-08-26 1981-02-19 Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
SE8206250L (sv) * 1982-11-03 1984-05-04 Chemical Dynamics Sweden Ab Reglering av tarmmikroflora

Also Published As

Publication number Publication date
ES8700938A1 (es) 1986-11-16
US4767623A (en) 1988-08-30
JPS62500722A (ja) 1987-03-26
DK172252B1 (da) 1998-02-09
CA1266234A (en) 1990-02-27
SE8405587L (sv) 1986-05-09
AU589384B2 (en) 1989-10-12
JPH0720876B2 (ja) 1995-03-08
ES557029A0 (es) 1987-05-16
SE8405587D0 (sv) 1984-11-08
ATE81290T1 (de) 1992-10-15
FI862863A (fi) 1986-07-07
DK325486D0 (da) 1986-07-08
EP0201579B1 (en) 1992-10-07
DK325486A (da) 1986-07-08
SE463598B (sv) 1990-12-17
ES8705229A1 (es) 1987-05-16
DE3586744T2 (de) 1993-04-01
FI85810C (fi) 1992-06-10
EP0201579A1 (en) 1986-11-20
WO1986002837A1 (en) 1986-05-22
DE3586744D1 (de) 1992-11-12
FI862863A0 (fi) 1986-07-07
AU5097285A (en) 1986-06-03
FI85810B (fi) 1992-02-28

Similar Documents

Publication Publication Date Title
ES549313A0 (es) Procedimiento para aumentar la adherencia de las bacterias en el estomago e intestinos de seres humanos y animales
Grattan-Smith et al. Clinical and neurophysiological features of tick paralysis.
SE8803141D0 (sv) Neringsmedel for menniskor och djur
McCay et al. Experimental prolongation of the life span
DE3851203D1 (de) Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
ATE86826T1 (de) Methylsulfonylmethan enthaltende ernaehrungsprodukte und deren verwendungen.
ES2106785T3 (es) Medicamentos, su preparacion y empleo como analgesicos y/o antiinflamatorios para seres humanos y animales.
Davies A major epidemic of anthrax in Zimbabwe
Ihde et al. Conflict of concepts in early vitamin studies
IT8483359A0 (it) Procedimento per ottenere lapreparazione di concentrati e nutrimenti proteici dal sangue animale.
DK481589A (da) Lipidmetabolismefremmende middel
ES2061313T3 (es) Nadh y nadph como sustitutos energeticos.
KR840002238A (ko) 피부용보습제의 제조법
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
ES553196A0 (es) Procedimiento para la obtencion del acido propionico, sal amonica (2:1), y productos derivados utilizables en la conservacion de alimentos para consumo humano y animal
Steele The socioeconomic responsibilities of veterinary medicine
ATE96801T1 (de) Delta 23-derivate von ll-f28249-verbindungen.
FR2618439B1 (fr) Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
DE3781682D1 (de) Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.
FI862607A0 (fi) Vaccin och foerfarande foer dess framstaellning.
Ramsay et al. Isolation of Erysipelothrix rhusiopathiae from lesions of distal extremity necrosis in a captive king vulture.
Cowgill Recent Studies in the Physiology of Vitamin B
Grignet et al. Birdraisers' disease. 22 Case reports and immunoelectrophoretic study of 100 pigeon fanciers presumed to have respiratory symptoms.).
Reavill Septic thrombosis in a great curassow (Crax rubra)
Sollberger In memoriam professor Ture Petrén